AHA 24: VALOR-HCM: Mavacamten in Patients with Obstructive HCM Referred for Septal Reduction Therapy

(10:31)

2024 Guideline for the Management of Hypertrophic Cardiomyopathy

(16:58)

Hypertrophic Cardiomyopathy Webinar Series Part 1: Unmasking HCM and Revealing Clinical Wisdoms

(1:5:4)

EXPLORER-HCM trial results - Daniel Jacoby, MD

(8:19)

AHA HCM Registry, Recognition, and Site Certification Initiative

(4:53)

AHA 24: Mavacamten: Real-World Experience from 22 Months of the REMS Program

(7:20)

Session 1: Welcome to the Hypertrophic Cardiomyopathy (HCM) Connection Forum

(8:36)

HCM: Lifestyle Interventions and Exercise Recommendations

(29:8)

HCM Update

(27:37)

Dr. Matthew Martinez on the AHA/ACC Multisociety HCM Guideline Update

(5:19)

Living with hypertrophic cardiomyopathy: Bill’s story

(2:24)

Hypertrophic Cardiomyopathy Webinar Series Part 2: Clinical Case Reviews and Insights

(1:20:56)

Living with hypertrophic cardiomyopathy

(2:15)

2024 ACC/AHA/Multisociety Guidelines for Management of Hypertrophic Cardiomyopathy Released

(6:27)

RESET-HCM

(3:38)

Living with hypertrophic cardiomyopathy: Ross’s story

(2:11)

Session 4: Components of HCM Care: Strategies for Collaboration and Team-Based Care

(30:27)

HCM Updates 2020 ACC/AHA Guidelines

(1:22:36)

Session 3: From Clinician to Patient: A Physician’s HCM Journey

(25:44)